The use of cocaine, methamphetamine, and other amphetamine-type stimulants (e.g., MDMA or prescription stimulants) is a growing problem in the United States. According to the 2018 National Survey on Drug Use and Health, 5.9 million people aged 12 or older used cocaine in the past year, 2 million used methamphetamine, and 4.9 million misused prescription stimulants.
People with substance use disorders, including those with stimulant use disorders, often access the healthcare system via primary and ambulatory care settings for reasons other than their substance use disorder, and do not seek or are unable to access specialty treatment.
To address this issue, the AHRQ Academy has new content for treating stimulant use disorders in primary care settings.
- [NEW] Stimulant Use Disorder and Behavioral Health Integration - This topical page presents available research evidence, practical information, and resources for treating stimulant use disorders in primary and ambulatory care practices.
- [UPDATED] Medication-Assisted Treatment (MAT) for Opioid Use Disorder (OUD) Tools and Resources - This searchable collection offers a variety of tools and resources for offering or using MAT services for OUD in primary care settings. The latest addition to this collection includes tools and resources related to stimulant and opioid co-use.